Sign In

AASLD Events

Aug 31
Frailty the "Sixth Vital Sign" in Cirrhosis – How Do We Diagnose It and What Can We Do When We Find It?
Sep 11
Fibrosis Regression: Mechanisms and Clinical Consequences
Sep 14
Chronic Hepatitis B and Pregnancy: Management and Prevention of Vertical Transmission
Sep 15
Acute on Chronic Liver Failure: Is it Ready for Clinical Practice?
Sep 19
Surrogate Endpoints in Primary Sclerosing Cholangitis
View Full Calendar of Liver-Related Events
Download AASLD Calendar to iCal

What's New

FDA approves Vosevi for Hepatitis C

Jul 20
The U.S. Food and Drug Administration has approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

Should we screen for cirrhosis?

Jul 18
Recent guidelines are right to recommend screening high risk patients for cirrhosis, say liver specialists Mark Hudson at Freeman Hospital, Newcastle upon Tyne, and Nick Sheron at Southampton General...

Study reveals cells can be reprogrammed to repair severe liver injury

Jul 13
A new study has revealed that bile duct cells can switch to become normal liver cells to help repair the liver after severe damage.
View All News

Publications

Featured Resources

Liver Transplantation

Liver Transplantation is the official journal of AASLD. This journal contains the latest research findings, as well as other relevant scientific... Read More

See All

Featured Resources

Member Spotlight

Christina Lindenmeyer, MD

My development as an academic physician began with an introduction to basic science research and has grown into a dedication to the practice of evidence-based medicine.

Read More